E Loder

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Post-marketing experience with an opioid nasal spray for migraine: lessons for the future
    E Loder
    Harvard Medical School, Boston, MA, USA
    Cephalalgia 26:89-97. 2006
  2. doi request reprint The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines
    Elizabeth Loder
    Graham Headache Center and the Department of Neurology, Division of Headache and Pain, Brigham and Women s and Faulkner Hospitals, Boston, MA, USA
    Headache 52:930-45. 2012
  3. pmc The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
    Carl Dahlof
    Gothenburg Migraine Clinic, c o Läkarhuset, Södra vägen 27, S 41135 Gothenburg, Sweden
    Health Qual Life Outcomes 5:56. 2007
  4. ncbi request reprint Menstrual migraine: clinical considerations in light of revised diagnostic criteria
    E Loder
    Faculty of Medicine, Harvard Medical School, 125 Nashua Street, Boston, MA 02114, USA
    Neurol Sci 26:s121-4. 2005
  5. ncbi request reprint Headache attributed to psychiatric disorder: a case series
    Elizabeth Loder
    Harvard Medical School, Boston, MA, USA
    Psychosomatics 46:326-33. 2005
  6. ncbi request reprint Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine
    Elizabeth W Loder
    Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA 02114, USA
    Curr Med Res Opin 21:S8-12. 2005
  7. ncbi request reprint Cluster headache and the heart
    Elizabeth Loder
    Headache Management Program, Spaulding Rehabilitation Hospital, 125 Nashua Street, Boston, MA 02114, USA
    Curr Pain Headache Rep 10:142-6. 2006
  8. ncbi request reprint Cluster headache treatment dilemmas: the experts respond
    Elizabeth Loder
    1153 Centre Street, Boston, MA 02130, USA
    Curr Pain Headache Rep 11:141-7. 2007
  9. ncbi request reprint Migraine in pregnancy
    Elizabeth Loder
    Division of Headache and Pain, Department of Neurology, Brigham and Women s Faulkner Hospital, Boston, Massachusetts 02130, USA
    Semin Neurol 27:425-33. 2007
  10. pmc Tension-type headache
    Elizabeth Loder
    Division of Headache and Pain, Department of Neurology, Brigham and Women s Faulkner Hospitals, Harvard Medical School, Boston, MA, USA
    BMJ 336:88-92. 2008

Detail Information

Publications32

  1. ncbi request reprint Post-marketing experience with an opioid nasal spray for migraine: lessons for the future
    E Loder
    Harvard Medical School, Boston, MA, USA
    Cephalalgia 26:89-97. 2006
    ..The implications of these lessons for future drug development and post-marketing surveillance in the migraine field are considered...
  2. doi request reprint The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines
    Elizabeth Loder
    Graham Headache Center and the Department of Neurology, Division of Headache and Pain, Brigham and Women s and Faulkner Hospitals, Boston, MA, USA
    Headache 52:930-45. 2012
    ..We review the characteristics, methods, consistency, and quality of the AHS/AAN guidelines in comparison with recently issued guidelines from other specialty societies...
  3. pmc The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
    Carl Dahlof
    Gothenburg Migraine Clinic, c o Läkarhuset, Södra vägen 27, S 41135 Gothenburg, Sweden
    Health Qual Life Outcomes 5:56. 2007
    ..001). The MSQ measures how much migraine limits/interrupts daily performance. Pooled analyses of pivotal trial data were conducted to further assess how topiramate 100 mg/d affects daily activities and patient functioning...
  4. ncbi request reprint Menstrual migraine: clinical considerations in light of revised diagnostic criteria
    E Loder
    Faculty of Medicine, Harvard Medical School, 125 Nashua Street, Boston, MA 02114, USA
    Neurol Sci 26:s121-4. 2005
    ..This paper reviews evidence for specific acute and pre-emptive treatment strategies, including the use of hormonal supplementation, scheduled triptans and nonsteroidal anti-inflammatory drugs...
  5. ncbi request reprint Headache attributed to psychiatric disorder: a case series
    Elizabeth Loder
    Harvard Medical School, Boston, MA, USA
    Psychosomatics 46:326-33. 2005
    ..The revised headache classification system appropriately recognizes headaches attributed to psychiatric disorder as a form of secondary headache...
  6. ncbi request reprint Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine
    Elizabeth W Loder
    Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA 02114, USA
    Curr Med Res Opin 21:S8-12. 2005
    ..Adverse events observed with zolmitriptan ODT were similar to those associated with the serotonin1B/1D agonists as a class, and were generally transient and of mild or moderate intensity...
  7. ncbi request reprint Cluster headache and the heart
    Elizabeth Loder
    Headache Management Program, Spaulding Rehabilitation Hospital, 125 Nashua Street, Boston, MA 02114, USA
    Curr Pain Headache Rep 10:142-6. 2006
    ..In addition, a number of important treatment options for cluster headache have effects on cardiovascular function that must be considered in planning therapy. The implications of these findings for clinical practice are discussed...
  8. ncbi request reprint Cluster headache treatment dilemmas: the experts respond
    Elizabeth Loder
    1153 Centre Street, Boston, MA 02130, USA
    Curr Pain Headache Rep 11:141-7. 2007
    ....
  9. ncbi request reprint Migraine in pregnancy
    Elizabeth Loder
    Division of Headache and Pain, Department of Neurology, Brigham and Women s Faulkner Hospital, Boston, Massachusetts 02130, USA
    Semin Neurol 27:425-33. 2007
    ..Women with migraine have an increased risk for several serious pregnancy complications, but there is little convincing evidence of an increase in neonatal complications. Migraine is not a contraindication to breast-feeding...
  10. pmc Tension-type headache
    Elizabeth Loder
    Division of Headache and Pain, Department of Neurology, Brigham and Women s Faulkner Hospitals, Harvard Medical School, Boston, MA, USA
    BMJ 336:88-92. 2008
  11. doi request reprint Tolerance and loss of beneficial effect during migraine prophylaxis: clinical considerations
    Elizabeth W Loder
    John R Graham Headache Center and Division of Headache and Pain, Department of Neurology, Brigham and Women s Faulkner Hospitals, Boston, MA, USA
    Headache 51:1336-45. 2011
    ..Selected behavioral and environmental treatment techniques might also be useful. We describe a practical, structured approach to evaluation and management of relapse with migraine prophylaxis...
  12. ncbi request reprint Conclusion: how primary care physicians can help their patients with migraine
    Elizabeth W Loder
    Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
    Am J Med 118:45S-46S. 2005
  13. ncbi request reprint Migraine diagnosis and treatment
    Elizabeth Loder
    Harvard Medical School, 25 Shattuck Street, Boston, MA 02114, USA
    Prim Care 31:277-92, vi. 2004
    ..Guidelines are available that summarize the quality of evidence for individual interventions, but treatment must be individualized...
  14. ncbi request reprint Use of botulinum toxins for chronic headaches: a focused review
    Elizabeth Loder
    Harvard Medical School, Headache and Pain Management Programs, Spaulding Rehabilitation Hospital, Boston, Massachusetts, USA
    Clin J Pain 18:S169-76. 2002
    ..Current data suggest that botulinum toxin is safe and does not produce systemic effects associated with other types of headache treatments...
  15. ncbi request reprint Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls
    E Loder
    Pain and Headache Management Programs, Spaulding Rehabilitation Hospital and Harvard Medical School, Boston, USA
    Cephalalgia 25:124-31. 2005
    ..These observations support the view that the inclusion of a placebo group remains of major scientific and ethical importance in trials of migraine medications...
  16. ncbi request reprint Stiff-person syndrome presenting with headache
    E Loder
    Headache and Pain Management Programs, The Spaulding Rehabilitation Hospital and Harvard Medical School, Boston, MA 02114, USA
    Cephalalgia 25:237-9. 2005
  17. ncbi request reprint Prophylaxis of menstrual migraine with triptans: problems and possibilities
    Elizabeth Loder
    Harvard Medical School and Pain and Headache Management Programs, Spaulding Rehabilitation Hospital, Boston, MA, USA
    Neurology 59:1677-81. 2002
    ..Triptans would have to show compelling advantages over other therapy to be a plausible prophylactic treatment for menstrual migraine...
  18. ncbi request reprint Cluster headache from the patient's point of view
    Elizabeth Loder
    Spaulding Rehabilitation Hospital, 125 Nashua Street, Boston, MA 02114, USA
    Curr Pain Headache Rep 9:120-5. 2005
    ..The patient responses provide important information for physicians and others who seek a more complete understanding of cluster headache...
  19. ncbi request reprint Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial
    Elizabeth Loder
    Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, USA
    Curr Med Res Opin 21:381-9. 2005
    ..Zolmitriptan 2.5 mg orally disintegrating tablets (ODT) allow patients to take the medication without fluids, which is convenient and avoids the risk of fluid-induced exacerbation of nausea/vomiting...
  20. ncbi request reprint Safety of sumatriptan in pregnancy: a review of the data so far
    Elizabeth Loder
    Harvard Medical School, Boston, Massachusetts, USA
    CNS Drugs 17:1-7. 2003
    ..However, current information is not sufficient to rule out small increases in the risk for birth defects. For this reason, caution should be exercised in making a positive recommendation for the use of sumatriptan during pregnancy...
  21. ncbi request reprint What is the evolutionary advantage of migraine?
    E Loder
    Headache and Pain Management Programs, Spaulding Rehabilitation Hospital, and Harvard Medical School, Boston, MA 02114, USA
    Cephalalgia 22:624-32. 2002
    ..migraine as a design constraint. An evolutionary perspective on migraine allows the generation of important hypotheses about the disorder and suggests rewarding possibilities for further research...
  22. ncbi request reprint Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine
    E Loder
    Spaulding Rehabilitation Hospital, Boston, MA, USA
    Headache 41:745-53. 2001
    ..CONCLUSIONS: A significantly greater proportion of patients preferred rizatriptan ODT 10-mg to sumatriptan 50-mg tablet for the acute treatment of migraine. Efficacy and safety data are consistent with the preference findings...
  23. doi request reprint Postpartum headache
    A M Klein
    Department of Neurology, Harvard Medical School, Boston, MA, USA
    Int J Obstet Anesth 19:422-30. 2010
    ..A structured approach to headache evaluation in the postpartum patient will be presented to help differentiate the possible causes of headache...
  24. ncbi request reprint Off-label prescribing of drugs in specialty headache practice
    Elizabeth W Loder
    Harvard Medical School, Headache Management Program, Spaulding Rehabilitation Hospital, Boston, MA, USA
    Headache 44:636-41. 2004
    ..To assess the extent of off-label prescribing in specialty headache practice...
  25. ncbi request reprint Migraine: primary care challenges in diagnosis and treatment. Introduction
    Richard B Lipton
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA
    Am J Med 118:1S-2S. 2005
  26. ncbi request reprint A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine
    Joel R Saper
    Michigan Head Pain and Neurological Institute, Ann Arbor, Michigan, USA
    Pain Med 8:478-85. 2007
    ..However, the optimal treatment paradigm and patient population have yet to be defined...
  27. ncbi request reprint Evaluating the triptans
    Ninan T Mathew
    Houston Headache Clinic, and Department of Neurology, University of Texas Medical School, Houston, Texas 77004, USA
    Am J Med 118:28S-35S. 2005
    ..Data from published comparator trials, based on commonly used efficacy end points and pharmacokinetic properties underlying patient-preferred outcomes, are reviewed in this article...
  28. ncbi request reprint The quality of headache treatment in the United States: review and analysis of recent data
    Elizabeth W Loder
    The Spaulding Rehabilitation Hospital, Headache Program, Boston, MA 02114, USA
    Headache 45:939-46. 2005
    ..Professional headache societies need to devote considerable resources to address the problem of widespread and important deficiencies in simple, fundamental care processes for headache...
  29. ncbi request reprint Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review
    Elizabeth W Loder
    Department of Medicine, Harvard Medical School, Boston, MA, USA
    Am J Obstet Gynecol 193:636-49. 2005
    ..We conducted a 2-part systematic review of published studies to examine the evidence that combination oral contraceptives can aggravate or cause headache...
  30. ncbi request reprint Migraine with aura during pregnancy
    Randolph W Evans
    1200 Binz 1370, Houston, TX 77004, USA
    Headache 43:80-4. 2003
  31. ncbi request reprint Menstrual migraine: pathophysiology, diagnosis, and impact
    Elizabeth W Loder
    Harvard Medical School, Graham Headache Centre, Boston, MA 02130, USA
    Headache 46:S55-60. 2006
    ..Moreover, compared with headaches that occur during other times in the cycle, menstrual migraines are more severe in most women and may be of longer duration, as well as more resistant to treatment in a subset of women...
  32. ncbi request reprint Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice
    Elizabeth W Loder
    Spaulding Rehabilitation Hospital, Headache and Pain Program, Boston, MA, USA
    Headache 45:224-31. 2005
    ..The authors' recommendations regarding OC use in various primary headache disorders are summarized...